Biofrontera Inc. announces preliminary product revenues for the First Quarter of 2022. Product revenues for the first quarter of 2022 are anticipated to be in the range of approximately $9.5 million to $10.0 million, representing an increase of approximately 102% to 113% compared with the first quarter of 2021.